Evidence for reduced antibody protection against SARS-CoV-2 variants

Researchers have found that the SARS-CoV-2 variants B.1.351 and P.1 are no longer inhibited by an antibody used for COVID-19 therapy. In addition, these variants are less efficiently inhibited by antibodies from recovered patients and vaccinated individuals. View original article here Source

Related Posts